Jeremy Sohn

Mr. Sohn is a serial technology entrepreneur and venture capitalist. He is currently the VP, Head of Business Development and Licensing at Novartis where he is responsible for leading all-digital, technology driven, business development activities. Prior to Novartis, Jeremy was a Managing Director at MPM Capital where he was responsible for leading MPM’s life sciences-focused digital innovation investment strategy. At MPM, Jeremy personally founded two companies: CentrosHealth (acquired by Clinical Ink in March 2015), a mobile, patient-engagement platform designed to improve the patient experience during clinical trials, and TriNetX, a federated network of clinical data warehouses that optimizes clinical trial protocol design and patient recruitment. Jeremy is a frequent speaker on digital innovation within healthcare and life sciences and is a member of the Advisory Committee for SMART Platforms.org, a public-private consortium developing an open source data interoperability platform that enables third-party application development and integration with EHRs. Jeremy graduated cum laude from Princeton University’s Woodrow Wilson School of Public and International Affairs, with a focus on biotechnology and medical policy.

.